|
Yale SPORE in Skin Cancer
|
4P50CA121974-10
|
$2,161,999
|
$2,161,999
|
HALABAN, RUTH
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$17,017
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$8,400
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$17,588
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$28,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$67,883
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$70,350
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$364,001
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
Xenobiotic receptors
|
ZIA BC 005562
|
$719,839
|
$71,984
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-04S1
|
$170,764
|
$27,322
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Women's Health Initiative Cancer Survivor Cohort
|
4UM1CA173642-04
|
$2,396,733
|
$383,477
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$40,711
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$2,400
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$81,553
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
Why red-haired individuals are so prone to developing melanoma
|
5R01CA196896-02
|
$374,464
|
$374,464
|
CUI, RUTAO
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
VISTA, a novel checkpoint that suppresses anti-tumor T cell responses
|
5R01CA164225-05
|
$15,589
|
$15,589
|
WANG, LI
|
MEDICAL COLLEGE OF WISCONSIN
|
|
Vesicular stomatitis VSVrp30 selectively destroys human metastatic melanoma
|
4R01CA161048-05
|
$345,488
|
$345,488
|
VAN DEN POL, ANTHONY
|
YALE UNIVERSITY
|
|
Vesicular Stomatitis Virus (VSV) Replication in Malignant Cells
|
5R01CA194404-02
|
$332,363
|
$99,709
|
BARBER, GLEN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of circulating tumor DNA assays for detection of metastatic melanoma
|
1UH2CA206124-01
|
$211,875
|
$211,875
|
POLSKY, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
|
Validation and humanization of a PET imaging agent that targets PD-L1.
|
1R43CA203138-01A1
|
$300,000
|
$300,000
|
GOSTISSA, MONICA
|
AGENUS, INC.
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$8,750
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$300,195
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$23,852
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Unraveling the molecular control of a pro-metastatic regulatory network in melanoma
|
1R01CA184804-01A1
|
$387,731
|
$387,731
|
TAVAZOIE, SOHAIL
|
ROCKEFELLER UNIVERSITY
|
|
Unlocking Tumor Immunophenotype in Responders versus Non-Responders in Metastatic Uveal Melanoma Patients Receiving Immune Checkpoint Blockade
|
1R21CA208609-01
|
$203,580
|
$203,580
|
PATEL, SAPNA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
2P30CA134274-09
|
$2,259,773
|
$112,989
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S1
|
$124,964
|
$6,248
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S2
|
$200,219
|
$10,011
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-09S3
|
$629,550
|
$31,478
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S1
|
$60,000
|
$4,800
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S2
|
$125,000
|
$10,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S3
|
$246,015
|
$19,681
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S4
|
$96,787
|
$7,743
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-04S5
|
$199,999
|
$16,000
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
4P30CA177558-04
|
$2,107,000
|
$168,560
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
University of Colorado NTCN Lead Academic Participating Site (LAPS)
|
5U10CA180834-03
|
$768,950
|
$38,448
|
ELIAS, ANTHONY
|
UNIVERSITY OF COLORADO DENVER
|
|
Uniting Mass Spectrometry and Glycoscience to Investigate Cancer Biology
|
1F99CA212454-01
|
$33,141
|
$33,141
|
RILEY, NICHOLAS
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
3R01CA181633-03S1
|
$60,936
|
$60,936
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding Wnt5a regulation of protein depalmitoylation during cell migration
|
5R01CA181633-03
|
$332,000
|
$332,000
|
WITZE, ERIC
|
UNIVERSITY OF PENNSYLVANIA
|
|
Understanding the role of serine metabolism in cancer
|
5R21CA198028-02
|
$168,517
|
$168,517
|
VANDER HEIDEN, MATTHEW
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Understanding the role of Polycomb Repressive Complex 2 in melanoma
|
5F31CA192813-02
|
$43,576
|
$43,576
|
DINAPOLI, SARA
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Understanding the mechanism of H3K9 HMT mediated suppression of melanoma
|
1F31CA213997-01
|
$44,406
|
$44,406
|
MARTINEZ-MCFALINE, RAUL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
UCDCCC NCTN U10 Program
|
5U10CA180846-03
|
$626,991
|
$15,675
|
GANDARA, DAVID
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Tumor-intrinsic oncogenic alterations and evasion of anti-tumor immunity
|
1K99CA204595-01
|
$111,690
|
$111,690
|
SPRANGER, STEFANI
|
UNIVERSITY OF CHICAGO
|
|
Tumor Microenvironment in Cancer Progression
|
ZIA BC 011332
|
$353,472
|
$17,674
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Tumor Genetics and Response to Checkpoint Blockade in Melanoma and Ovarian Cancer
|
1K08CA201544-01
|
$180,036
|
$90,018
|
SNYDER CHAREN, ALEXANDRA
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Translational Research in Cancer
|
3P30CA056036-17S1
|
$117,000
|
$9,360
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
Total relevant funding to Melanoma for this search: $142,932,957
|